Skip to content
Open access

Profiling tumor immune microenvironment of epithelial ovarian carcinoma

Sep 2026 · Oncoimmunology · Vol 15 · 0 citations · 53 references
Medicine

TL;DR

EOC is characterized by histotype-specific immune milieux defined by macrophage dominance, epithelial immune exclusion and dynamic immune remodeling during progression from borderline tumors to invasive carcinomas.

Abstract

ABSTRACT Background Epithelial ovarian carcinoma (EOC) comprises five main histological subtypes: high-grade serous (HGSOC), low-grade serous (LGSOC), clear cell (CCOC), mucinous (MOC), and endometrioid (ENOC). Each histotype harbors specific genomic alterations and clinical outcome. Few studies systematically compared the tumor immune microenvironment across the five subtypes. Methods We performed 7-plex (CD45, CD8, CD68, CD163, FoxP3, CD20, and cytokeratin) sequential immunohistochemistry on a clinically annotated tissue microarray including 139 EOC representing the five subtypes and 26 borderline tumors (serous and mucinous). Digital pathology was used to quantify immune cell abundance, their spatial distribution (stroma vs tumor core), and correlation with survival. Results Immune cells were dominated by macrophages and more abundant in the stroma than tumor core across the five subtypes, consistent with immune excluded pattern. Compared to HGSOC, CCOC displayed the highest infiltration by CD45+ leukocytes and CD68+ macrophages, particularly M2-like CD163+ cells, suggesting a macrophage-rich, immunosuppressive phenotype. LGSOC exhibited the highest infiltration by intraepithelial FoxP3+ regulatory T cells. Comparison of borderline tumors with invasive carcinoma (LGOSC and MOC) revealed that malignant progression is accompanied by loss of CD8+ T cells, enrichment in regulatory T cells and increase of CD163+/CD68+ ratio, consistent with immune evasion during tumorigenesis. There was a trend toward better survival in HGSOC highly infiltrated by lymphocytes, either intraepithelial (CD8+ and FoxP3+) or stromal (FoxP3+ and CD20+). Conclusions EOC is characterized by histotype-specific immune milieux defined by macrophage dominance, epithelial immune exclusion and dynamic immune remodeling during progression from borderline tumors to invasive carcinomas.

Read PDF

Similar papers

Open access Sep 2026

BRCA1/2-stratified immune profiling of treatment-naive high-grade serous ovarian cancer ascites identifies a Treg-enriched ascitic immune phenotype

HGSOC ascites showed a Treg-enriched immune profile, with relatively higher Treg levels in BRCA-wild-type cases, while BRCA-wild-type status was associated with poorer outcomes, while the evaluated immune-cell subsets were not independently prognostic in exploratory analysis.

Megha Sharma, Bhavneet Kaur, B. Rai et al. · 0 citations
Open access Aug 2026

Histomorphological features and PD-L1 expression in canine gastric carcinoma using full thickness biopsy

Canine gastric carcinoma (CGC) is a rare and aggressive malignancy in dogs with poor clinical outcomes. The biological relevance of microscopic tumor architecture and immune microenvironmental features in CGC is poorly defined. This study assessed key histomorphological features, including mitotic count, tumor budding,...

Fabian Z. X. Lean, Morgan L. Tibbles, Bronwen Hulme et al. · 0 citations
Open access 2026

IMMUNOLOGICAL PROFILE OF SEROUS OVARIAN CARCINOMA AND DUCTAL BREAST CARCINOMA

Objective: To evaluate the immunological profile of serous ovarian carcinoma and ductal breast carcinoma, as well as the activity of apoptotic markers as a prognostic factor of sensitivity to immunotherapy. Methods: The study included 53 patients with serous ovarian adenocarcinoma, stage II-III, or breast cancer T2-4N0...

I. Golovkin, K. Aliev, T. Makalish et al. · 0 citations
Open access Aug 2026

Stromal CD10 as a Tumor Microenvironment Immuno marker in Colorectal Carcinoma: Association with Clinicopathological Parameters

Background: Colorectal carcinoma (CRC) is the third most common malignancy worldwide, posing a major public health challenge. Tumor–stromal interactions are increasingly recognized as potential therapeutic targets. CD10 has been implicated in tumor aggressiveness, with altered expression linked to the development of va...

Harun Or Rashid, Ruksana Jeba, Md. Abdullah Yeamin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.